Noha Eisa
Overview
Explore the profile of Noha Eisa including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
25
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Salmanton-Garcia J, Marchesi F, Navratil M, Piukovics K, Del Principe M, Criscuolo M, et al.
Am J Hematol
. 2024 Dec;
100(3):358-374.
PMID: 39715069
Community-acquired respiratory viral infections (CARV) significantly impact patients with hematological malignancies (HM), leading to high morbidity and mortality. However, large-scale, real-world data on CARV in these patients is limited. This...
2.
Alkhaldy H, M Algarni A, Eisa N, Asiri H, Alasiri H, Assiri M, et al.
Clin Lab
. 2024 Jun;
70(6).
PMID: 38868887
Background: Polycythemia is a common medical problem, frequently acquired and reactive to secondary conditions. High-altitude-associated hypoxia contributes to the greater prevalence of polycythemia at altitude. Primary clonal polycythemia vera (PV),...
3.
Aiello T, Salmanton-Garcia J, Marchesi F, Weinbergerova B, Glenthoj A, van Praet J, et al.
Haematologica
. 2024 Apr;
109(8):2693-2700.
PMID: 38572549
No abstract available.
4.
Salmanton-Garcia J, Marchesi F, Farina F, Weinbergerova B, Itri F, Davila-Valls J, et al.
EClinicalMedicine
. 2024 Mar;
71:102553.
PMID: 38533127
Background: The COVID-19 pandemic heightened risks for individuals with hematological malignancies due to compromised immune systems, leading to more severe outcomes and increased mortality. While interventions like vaccines, targeted antivirals,...
5.
Jamal E, Azmy E, Ayed M, Aref S, Eisa N
J Hematol
. 2020 Aug;
9(3):62-70.
PMID: 32855754
Background: Natural killer (NK) function defects have been seen in many hematological malignancies, including acute myeloid leukemia (AML). AML is associated with deficient human leukocyte antigen (HLA) expression on leukemia...
6.
Kassem S, Fouda M, Akef A, Elnaghi K, Fahmi M, Eisa N, et al.
Leuk Lymphoma
. 2020 May;
61(9):2242-2245.
PMID: 32397841
No abstract available.
7.
El-Badrawy A, Gadelhak B, Helmy E, Farouk O, Fady T, Refky B, et al.
J Cancer Res Ther
. 2020 May;
16(1):60-65.
PMID: 32362610
Objective: The objective of this study is to review the multidetector computed tomography (MDCT) findings of synchronous lymphoma and other solid malignancies. Patients And Methods: This retrospective study included 18...
8.
El-Ashwah S, Eisa N, Denewer M, Essam Y, Atef B, El-Badrawy A, et al.
J Hematol
. 2020 Apr;
7(4):154-157.
PMID: 32300431
Osteolytic bone lesions and hypercalcemia without peripheral blasts B-cell acute lymphoblastic leukemia (B-ALL) are reported in children but rarely seen in adults. Herein, we described two patients with B-ALL presenting...
9.
Zaki M, Zalata K, El-Hawary A, Eisa N, Ashwah S, Shamaa S
J Hematol
. 2020 Apr;
7(3):124-127.
PMID: 32300426
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is aggressive hematopoietic malignancy derived from the precursors of plasmacytoid dendritic cells. The present study reported a case of a 35-year-old BPDCN patient, who...
10.
Eisa N, Nasef K, Emarah Z, Fattah M, Shamaa S
J Hematol
. 2020 Apr;
7(2):72-75.
PMID: 32300416
Microangiopathic hemolytic anemia (MAHA) may occur as a paraneoplastic syndrome in some solid tumors, but MAHA accompanied by signet ring cell carcinoma (SRCC) of an unknown origin is very rare....